Hints and tips:
Related Special Reports
...Ogilvy, which has previously worked with a host of pharma groups including Pfizer and Johnson & Johnson, is launching a business that offers vetted influencers to talk about illnesses and possible solutions...
...“There’s been growing demand for V-neck sweaters, with searches for the style increasing by 10 per cent this year versus 2023,” says Daniel Todd, buying director of Mr Porter, where sales of the style have...
...Daniel Loeb’s Third Point gained nearly $400m in a bullish bet on the outcome of the US election, positioning the billionaire as one of the hedge fund winners from recent market gyrations....
...Rivals AstraZeneca, Johnson & Johnson, Russia’s Sputnik V and new entrants such as Novavax make up the remainder of the market, which is forecast to double in value to $124bn next year....
...The AU will pay $6.75 a dose for the BioNTech/Pfizer vaccine and $10 for Johnson & Johnson’s, a single-dose product....
...Additional reporting by Guy Chazan in Berlin, Joe Miller in Frankfurt and Daniel Dombey in Madrid...
...The vaccination campaign started after the EU’s medicine regulator approved the BioNTech/Pfizer vaccine, the first Covid-19 shot to get the green light, on Monday....
...“Together with Pfizer, we are also working with various organisations to support the supply of vaccines to populations worldwide....
...After such strong reads from the first two releases (three if we count Russia’s Sputnik V), the disappointing AZN figures were perhaps bound to prompt downward pressure on the company’s shares....
...It was their company, BioNTech, that produced the Pfizer vaccine....
...In August, Russia became the first country to approve a Covid-19 vaccine — named Sputnik V — for civilian use, but western experts cast doubt on its efficacy and safety....
...A version of this article was first published by Nikkei Asia on October 19 2021. ©2021 Nikkei Inc. All rights reserved....
...Additional reporting by Guy Chazan in Berlin, Daniel Dombey in Madrid and Leila Abboud in Paris...
...‘Perfect scenario’ Those look like V-shaped projections, Andrew Glenn thought to himself....
...“This is not going to be a V-shaped recovery from here given the many months [or] years it will take for full repair, but it feels good now.”...
...But all that will have to wait for now, perhaps until next year as a coronavirus vaccine breakthrough by Pfizer and Germany’s BioNTech offers a glimmer of hope just in time for the holidays....
...“She prefers to storm ahead, without consulting anyone, and do everything herself,” wrote Ulrike Demmer and Daniel Goffart in a von der Leyen biography that was published in 2015....
...Anyway, there’s much to enjoy in the paper for policy wonks, technologists or historians, so do have a read if you want a break from wondering whether we’ll have a V-shaped recovery or not....
...“Markets are pricing a V [shaped recovery], everyone’s coming back to work, and this is going to be fine,” Mr Falco said. “I don’t think it’s going to be that easy quite frankly.”...
...Early last year Bristol-Myers Squibb purchased Celgene for $93bn, while Pfizer snapped up Array BioPharma for $11bn in June....
...Boorstin, librarian of US Congress, Washington, DC, July 29 1976 Fifth row: Felix Rohatyn, chairman, Municipal Assistance Corporation, New York, April 15 1976; William Paley, chairman, CBS Inc, New York...
...(FT) News round-up Pfizer to boost cancer treatment portfolio with $11.4bn Array deal (FT) Nissan expands internal investigation into Carlos Ghosn (FT) Deutsche Bank to set up €50bn ‘bad bank’ as part...
...Idexx said in October that the animal health market had experienced a “V-shaped recovery”....
...The 1984 case, formally known as “Chevron USA Inc v Natural Resources Defense Council Inc” formalised the legal doctrine that requires judges to defer to administrative agencies’ interpretation of federal...
...A decade ago, Jeffrey Kindler, then chief executive of US drugs giant Pfizer, was plotting an audacious $68bn acquisition of rival Wyeth....
International Edition